Cargando…
Prediction of T-cell epitopes of hepatitis C virus genotype 5a
BACKGROUND: Hepatitis C virus (HCV) is a public health problem with almost 185 million people estimated to be infected worldwide and is one of the leading causes of hepatocellular carcinoma. Currently, there is no vaccine for HCV infection and the current treatment does not clear the infection in al...
Autores principales: | Gededzha, Maemu P, Mphahlele, M Jeffrey, Selabe, Selokela G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289306/ https://www.ncbi.nlm.nih.gov/pubmed/25380768 http://dx.doi.org/10.1186/1743-422X-11-187 |
Ejemplares similares
-
Characterization of HCV Genotype 5a Envelope Proteins: Implications for Vaccine Development and Therapeutic Entry Target
por: Gededzha, Maemu Petronella, et al.
Publicado: (2014) -
Hepatitis C Virus Genotype 5 Variability in Treatment-Naïve Patients in South Africa
por: Maunye, Tshegofatso K., et al.
Publicado: (2023) -
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
por: Lukhwareni, Azwidowi, et al.
Publicado: (2020) -
A novel hepatitis B virus recombinant genotype D4/E identified in a South African population
por: Matlou, Mmatsatsi K., et al.
Publicado: (2019) -
Genetic characterization of G12P[6] and G12P[8] rotavirus strains collected in six African countries between 2010 and 2014
por: Rakau, Kebareng G., et al.
Publicado: (2021)